AAIPharma News

News

AAIPharma Services and Cambridge Major Laboratories Announce the Appointments of Ted Dolan as Vice President, API Operations and Syed T. Husain as Vice President, API Business Unit

Germantown, Wis. Oct. 7, 2014 /Businesswire/ AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development and manufacturing, announce the appointments of Ted Dolan as Vice President, API Operations and Syed T. Husain as Vice President, API Business Unit. Read more >>

AAIPharma Services and Cambridge Major Laboratories Announce the Appointment of Marcel Schreuder Goedheijt as General Manager of Cambridge Major Laboratories – Europe

Weert, Netherlands. Sept. 30, 2014 /Businesswire/ AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development and manufacturing, announce the appointment of Marcel Schreuder Goedheijt, Ph.D. as General Manager, Cambridge Major Laboratories – Europe. Read more >>

AAIPharma Services and Cambridge Major Laboratories Announce Stephan Kutzer as Chief Executive Officer

WILMINGTON, N.C.  July 8, 2014/Businesswire/ AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, Inc (“CML”), a global leader in pharmaceutical API development and manufacturing, announce the appointment of Stephan Kutzer, Ph.D. as Chief Executive Officer (CEO), effective August 1, 2014. Read more >>

AAIPharma Services and Cambridge Major Laboratories Announce Patrick Walsh’s resignation as Chief Executive Officer

WILMINGTON, N.C.  April 8, 2014 /Businesswire/ AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development and manufacturing (collectively the “Companies”), announce the resignation of Patrick Walsh as Chief Executive Officer together with the appointment of interim CEO, Susan Nestegard. Read more >>